DOI: 10.12688/f1000research.157481.2 ISSN: 2046-1402

Global and regional projections of the economic burden of Asthma: a value of statistical life approach

Jefferson Antonio Buendia, Andres F. Zuluaga, Carlos Enrique Martínez-Rodríguez
Show PDF Cite
Introduction Asthma imposes a substantial economic burden on health systems. By understanding the economic burden and its projections, public health officials and governments can design more effective asthma management and prevention strategies. This study aimed to estimate the global economic burden of asthma. Methods We projected future year DALYs lost to asthma based on age- and country-specific YLL and YLD rates and their annual rates of change derived from the Institute for Health Metrics and Evaluation’s (IHME) Global Burden of Diseases (GBD) study for 1990–2021. We applied the concept of value of a statistical life year (VSLY) to estimate the value of a year of life lost to asthma. Results Our study reveals a disparity between high-income countries (HICs) and low- and middle-income countries (LMICs). The economic burden in low-income countries is expected to increase from 1,090 million dollars in 2023 to 1,265 million dollars in 2050, reflecting both population growth and increased prevalence of asthma. Meanwhile, high-income countries face a much higher burden, with costs rising from 130,290 million dollars in 2023 to 133,370 million dollars in 2050 Conclusion Our study reveals that the economic impact of asthma is projected to increase significantly globally, with a greater growth in low- and middle-income countries compared to high-income countries. Our results show a consistent rise in the economic burden of asthma from 2023 to 2050, both in absolute terms and per capita.

More from our Archive